These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 2142089)
1. Effects of cromakalim, pinacidil and nicorandil on cardiac refractoriness and arterial pressure in open-chest dogs. Spinelli W; Follmer C; Parsons R; Colatsky T Eur J Pharmacol; 1990 Apr; 179(3):243-52. PubMed ID: 2142089 [TBL] [Abstract][Full Text] [Related]
2. The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle. Yanagisawa T; Hashimoto H; Taira N Br J Pharmacol; 1988 Oct; 95(2):393-8. PubMed ID: 2852521 [TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil. Yanagisawa T; Teshigawara T; Taira N Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290 [TBL] [Abstract][Full Text] [Related]
4. Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil. Wilson C; Coldwell MC; Howlett DR; Cooper SM; Hamilton TC Eur J Pharmacol; 1988 Aug; 152(3):331-9. PubMed ID: 2851450 [TBL] [Abstract][Full Text] [Related]
5. A comparison between the effects of BMS-180448, a novel K+ channel opener, and cromakalim in rat and dog. D'Alonzo AJ; Darbenzio RB; Sewter JC; Hess TA; Grover GJ; Sleph PG; Normandin DE; Lodge NJ Eur J Pharmacol; 1995 Dec; 294(1):271-80. PubMed ID: 8788441 [TBL] [Abstract][Full Text] [Related]
6. Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery. Ksoll E; Parsons AA; Mackert JR; Schilling L; Wahl M Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):377-83. PubMed ID: 1830131 [TBL] [Abstract][Full Text] [Related]
7. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells. Satoh H J Cardiovasc Pharmacol; 1993 Dec; 22(6):863-8. PubMed ID: 7509906 [TBL] [Abstract][Full Text] [Related]
8. Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil. Longman SD; Clapham JC; Wilson C; Hamilton TC J Cardiovasc Pharmacol; 1988; 12(5):535-42. PubMed ID: 2468052 [TBL] [Abstract][Full Text] [Related]
9. [The vasospasmolytic effects of nicorandil, cromakalim and pinacidil on 3,4-diaminopyridine-induced phasic contractions in canine coronary arteries as an experimental vasospasm model]. Kamijo T; Tomaru T; Miwa A; Nakamura F; Kido H; Sugimoto T; Uchida Y Nihon Yakurigaku Zasshi; 1992 Oct; 100(4):317-27. PubMed ID: 1446882 [TBL] [Abstract][Full Text] [Related]
10. Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle. Satoh E; Yanagisawa T; Taira N Jpn J Pharmacol; 1990 Oct; 54(2):133-41. PubMed ID: 2150209 [TBL] [Abstract][Full Text] [Related]
11. Effect of three novel K+ channel openers, cromakalim, pinacidil and nicorandil on allergic reaction and experimental asthma. Nagai H; Kitagaki K; Goto S; Suda H; Koda A Jpn J Pharmacol; 1991 May; 56(1):13-21. PubMed ID: 1831870 [TBL] [Abstract][Full Text] [Related]
13. Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels. Minkes RK; Kvamme P; Higuera TR; Nossaman BD; Kadowitz PJ Am J Physiol; 1991 Mar; 260(3 Pt 2):H957-66. PubMed ID: 1825747 [TBL] [Abstract][Full Text] [Related]
14. Effects of pinacidil, cromakalim, and nicorandil on potassium currents of rat basilar artery smooth muscle. Zhang H; Stockbridge N; Weir B Adv Exp Med Biol; 1991; 304():531-41. PubMed ID: 1839488 [No Abstract] [Full Text] [Related]
15. Cardiohemodynamic effects of cromakalim and pinacidil, potassium-channel openers, in the dog, special reference to venous return. Gotanda K; Yokoyama H; Satoh K; Taira N Cardiovasc Drugs Ther; 1989 Aug; 3(4):507-15. PubMed ID: 2488102 [TBL] [Abstract][Full Text] [Related]
16. Vasodilatation of canine cerebral arteries by nicorandil, pinacidil and lemakalim. Zhang H; Stockbridge N; Weir B; Vollrath B; Cook D Gen Pharmacol; 1992 Mar; 23(2):197-201. PubMed ID: 1353469 [TBL] [Abstract][Full Text] [Related]
17. Prejunctional effects of cromakalim, nicorandil and pinacidil on noradrenergic transmission in rat isolated mesenteric artery. Fabiani ME; Story DF J Auton Pharmacol; 1994 Apr; 14(2):87-98. PubMed ID: 8051201 [TBL] [Abstract][Full Text] [Related]
18. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs. Yamada H; Yoneyama F; Satoh K; Taira N Br J Pharmacol; 1990 Jul; 100(3):413-6. PubMed ID: 2143956 [TBL] [Abstract][Full Text] [Related]
19. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery. Eltze M Eur J Pharmacol; 1989 Jun; 165(2-3):231-9. PubMed ID: 2528466 [TBL] [Abstract][Full Text] [Related]
20. Effects of cromakalim or glibenclamide on arrhythmias and dispersion of refractoriness in chronically infarcted in anesthetized dogs. D'Alonzo AJ; Sewter JC; Darbenzio RB; Hess TA Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):222-8. PubMed ID: 7477447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]